Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1972 Jan 29;1(5795):290–293. doi: 10.1136/bmj.1.5795.290

Hypothyroidism.

D Evered, R Hall
PMCID: PMC1787149  PMID: 4550378

Full text

PDF
290

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bastenie P. A., Bonnyns M., Neve P., Vanhaelst L., Chailly M. Clinical and pathological significance of asymptomatic atrophic thyroiditis. A condition of latent hypothyroidism. Lancet. 1967 Apr 29;1(7496):915–918. doi: 10.1016/s0140-6736(67)91486-9. [DOI] [PubMed] [Google Scholar]
  2. Bastenie P. A., Vanhaelst L., Bonnyns M., Neve P., Staquet M. Preclinical hypothyroidism: a risk factor for coronary heart-disease. Lancet. 1971 Jan 30;1(7692):203–204. doi: 10.1016/s0140-6736(71)90947-0. [DOI] [PubMed] [Google Scholar]
  3. Bastenie P. A., Vanhaelst L., Neve P. Coronary-artery disease in hypothyroidism. Lancet. 1967 Dec 9;2(7528):1221–1222. doi: 10.1016/s0140-6736(67)90562-4. [DOI] [PubMed] [Google Scholar]
  4. Cotton G. E., Gorman C. A., Mayberry W. E. Suppression of thyrotropin (h-TSH) in serums of patients with myxedema of varying etiology treated with thyroid hormones. N Engl J Med. 1971 Sep 2;285(10):529–533. doi: 10.1056/NEJM197109022851001. [DOI] [PubMed] [Google Scholar]
  5. Fowler P. B., Swale J., Andrews H. Hypercholesterolaemia in borderline hypothyroidism. Stage of premyxoedema. Lancet. 1970 Sep 5;2(7671):488–491. doi: 10.1016/s0140-6736(70)90111-x. [DOI] [PubMed] [Google Scholar]
  6. Fowler P. S., Swale J. Premyxoedema and coronary-artery disease. Lancet. 1967 May 20;1(7499):1077–1079. doi: 10.1016/s0140-6736(67)92650-5. [DOI] [PubMed] [Google Scholar]
  7. Hedley A. J., Amos J., Hall R., Michie W., Crooks J. Serum-thyrotropin levels after subtotal thyroidectomy for Graves' disease. Lancet. 1971 Mar 6;1(7697):455–458. doi: 10.1016/s0140-6736(71)91084-1. [DOI] [PubMed] [Google Scholar]
  8. LOWREY R., STARR P. Chemical evidence of incidence of hypothyroidism. Study of employed men and women, physicians, and professional blood donors. J Am Med Assoc. 1959 Dec 12;171:2045–2048. doi: 10.1001/jama.1959.03010330007003. [DOI] [PubMed] [Google Scholar]
  9. Ormston B. J., Cryer R. J., Garry R., Besser G. M., Hall R. Thyrotrophin-releasing hormone as a thyroid-function test. Lancet. 1971 Jul 3;2(7714):10–14. doi: 10.1016/s0140-6736(71)90005-5. [DOI] [PubMed] [Google Scholar]
  10. Smith R. N., Taylor S. A., Massey J. C. Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism. Br Med J. 1970 Oct 17;4(5728):145–148. doi: 10.1136/bmj.4.5728.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sterling K., Bellabarba D., Newman E. S., Brenner M. A. Determination of triiodothyronine concentration in human serum. J Clin Invest. 1969 Jun;48(6):1150–1158. doi: 10.1172/JCI106072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Vanhaelst L., Neve P., Chailly P., Bastenie P. A. Coronary-artery disease in hypothyroidism. Observations in clinical myxoedema. Lancet. 1967 Oct 14;2(7520):800–802. doi: 10.1016/s0140-6736(67)92235-0. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES